Lisa Rojkjaer - Net Worth and Insider Trading
Lisa Rojkjaer Net Worth
The estimated net worth of Lisa Rojkjaer is at least $30,530 dollars as of 2024-06-07. Lisa Rojkjaer is the Chief Medical Officer of Viracta Therapeutics Inc and owns about 48,087 shares of Viracta Therapeutics Inc (VIRX) stock worth over $30,530. Details can be seen in Lisa Rojkjaer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lisa Rojkjaer has not made any transactions after 2023-02-27 and currently still holds the listed stock(s).
Transaction Summary of Lisa Rojkjaer
Lisa Rojkjaer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lisa Rojkjaer owns 1 companies in total, including Viracta Therapeutics Inc (VIRX) .
Click here to see the complete history of Lisa Rojkjaer’s form 4 insider trades.
Insider Ownership Summary of Lisa Rojkjaer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VIRX | Viracta Therapeutics Inc | 2023-02-27 | Chief Medical Officer |
Lisa Rojkjaer Latest Holdings Summary
Lisa Rojkjaer currently owns a total of 1 stock. Lisa Rojkjaer owns 48,087 shares of Viracta Therapeutics Inc (VIRX) as of February 27, 2023, with a value of $30,530.
Latest Holdings of Lisa Rojkjaer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VIRX | Viracta Therapeutics Inc | 2023-02-27 | 48,087 | 0.63 | 30,530 |
Holding Weightings of Lisa Rojkjaer
Lisa Rojkjaer Form 4 Trading Tracker
According to the SEC Form 4 filings, Lisa Rojkjaer has made a total of 6 transactions in Viracta Therapeutics Inc (VIRX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Viracta Therapeutics Inc is the sale of 2,156 shares on February 27, 2023, which brought Lisa Rojkjaer around $3,622.
Insider Trading History of Lisa Rojkjaer
- 1
Lisa Rojkjaer Trading Performance
Lisa Rojkjaer Ownership Network
Lisa Rojkjaer Owned Company Details
What does Viracta Therapeutics Inc do?
Who are the key executives at Viracta Therapeutics Inc?
Lisa Rojkjaer is the Chief Medical Officer of Viracta Therapeutics Inc. Other key executives at Viracta Therapeutics Inc include Chief Executive Officer Daniel R. Chevallard , director & President and CEO Mark Rothera , and Chief Medical Officer Darrel P. Cohen .
Viracta Therapeutics Inc (VIRX) Insider Trades Summary
Over the past 18 months, Lisa Rojkjaer made 1 insider transaction in Viracta Therapeutics Inc (VIRX) with a net sale of 2,156. Other recent insider transactions involving Viracta Therapeutics Inc (VIRX) include a net sale of 17,871 shares made by Daniel R. Chevallard , a net purchase of 100,000 shares made by Mark Rothera ,
In summary, during the past 3 months, insiders sold 0 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 20,027 shares of Viracta Therapeutics Inc (VIRX) were sold and 100,000 shares were bought by its insiders, resulting in a net purchase of 79,973 shares.
Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Viracta Therapeutics Inc Insider Transactions
Lisa Rojkjaer Mailing Address
Above is the net worth, insider trading, and ownership report for Lisa Rojkjaer. You might contact Lisa Rojkjaer via mailing address: C/o Viracta Therapeutics, Inc., 2533 South Coast Hwy., Ste. 210, Cardiff Ca 92007.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
